SAVE H.B. FULLER

Ancora believes H.B. Fuller’s potential acquisition of UK-based Advanced Medical Solutions
— for a reported $800+
million price tag —
would saddle the organization with excessive debt, further distract an already underwhelming management team and lead to more declines in value given the size, scope and scale of the acquisition

Read Ancora’s Letter to the Board

If you are affiliated with or have an interest in H.B. Fuller, you have the ability to let the company's leadership know how you feel.

You have a small window of time now to act. We have shared our feedback with Chair Teresa Rasmussen.

EMAIL THE CHAIR

Send Your Feedback

You can also share private feedback with us through this form, or email SaveHBFuller@longacresquare.com

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Meet the individuals who started and can still stop the potential $800+ million gamble

Teresa (Terry) J. Rasmussen
Chair
Daniel L. Florness
Director
Thomas W. Handley
Director
Michael J. Happe
Director
Ruth S. Kimmelshue
Director
Charles (Chuck) T. Lauber
Director
Celeste B. Mastin
CEO & Director
Srilata (Sri) A. Zaheer
Director

We want to hear from you

Please anonymously submit your views or concerns.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Stay Updated

Enter your name & email address to receive updates:

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Investor Contact

Irenic Capital Management
contact@irenicmgmt.com

Media Contact

Longacre Square Partners
irenic@longacresquare.com